Japan to Revise Ad Guidelines to Address GLP-1 Use for Cosmetic Weight Loss

January 31, 2024
Japan’s Ministry of Health, Labor and Welfare (MHLW) will revise its advertising guidelines for medical institutions in response to an increase in illicit ads touting the off-label use of GLP-1 receptor agonists for aesthetic weight loss. A draft revision of...read more